en · de · es · fr · pt
assay-notes.peptides6088.com › Info › Identity And Molecular Background — Field Notes

Identity And Molecular Background — Field Notes

By Editorial Desk · published 2026-01-29 · last reviewed 2026-02-28 · Info

A practical reference on prothymosin alpha: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-02-28. Anything still debated is marked as such rather than presented as settled.

Identity and Molecular Background

Thymosin alpha 1 is a 28-amino-acid peptide first isolated from thymosin fraction 5, a bovine thymic extract. Its sequence begins with an acetylated serine residue and carries a high proportion of acidic residues, so the molecule has a net negative charge near neutral pH. Despite the shared name, it is unrelated in sequence to the thymosin beta family. Synthetic material prepared by solid-phase peptide synthesis is identical in sequence to the natural peptide.

Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.

Background and Mechanism of Action

Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.

Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.

Thymosin-alpha-1 at a glance

PropertyValueNotes
Molecular formulaC129H215N33O55Calculated for the acetylated 28-residue peptide
AppearanceWhite to off-white powderLyophilized solid recovered from aqueous buffer
SolubilityFreely soluble in waterTypically dissolved in water or buffer before use
Typical storage-20 C or below, desiccatedProtect from light and avoid repeated freeze-thaw cycles
Identity testingReverse-phase HPLC with mass spectrometryRetention time and measured mass confirm the sequence

Stability, Storage, and Analysis

Routine handling calls for storage of the lyophilized powder at refrigerated temperatures, away from light, in a sealed container. Working solutions are often prepared in sterile water or buffer and kept cold between uses. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation and loss of material. Laboratories usually record lot number, reconstitution date, and storage conditions so that any change in behavior can be traced to a specific preparation.

Reverse-phase high-performance liquid chromatography is the standard technique for assessing purity and concentration, because the peptide's hydrophobicity allows clean separation from related impurities. Mass spectrometry confirms molecular identity and detects sequence errors or truncations. Amino acid analysis and peptide mapping supply additional structural confirmation when required. Chromatographic purity values reported on certificates of analysis describe the proportion of the main peak and do not by themselves establish biological activity.

Related pages on this site

分子身份与天然来源

胸腺素α1(thymosin alpha 1,Tα1)是一种由28个氨基酸组成的酸性肽,N端被乙酰化,分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离,属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守,提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置,并非表示亚型编号。它既存在于胸腺,也存在于脾脏和淋巴结等免疫组织。

20世纪70年代,研究者从胸腺提取物中纯化出多种小肽,Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤,产量低且成分复杂。随着固相肽合成技术成熟,实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上,并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。

市售的胸腺素α1通常以冻干粉形式提供,溶解后用于注射。其氨基酸组成包括多个酸性残基,因此在中性pH下带负电荷。该肽可溶于水和生理盐水,但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度,溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。

Background from the literature

This method has been described as the most viable means of disposing of radioactive waste, and as the state-of-the-art as of 2001 in nuclear waste disposal technology. Another approach termed Remix & Return would blend high-level waste with uranium mine and mill tailings down to the level of the original radioactivity of the uranium ore, then replace it in inactive uranium mines. This approach has the merits of providing jobs for miners who would double as disposal staff, and of facilitating a cradle-to-grave cycle for radioactive materials, but would be inappropriate for spent reactor fuel in the absence of reprocessing, due to the presence of highly toxic radioactive elements such as plutonium within it. Deep borehole disposal is the concept of disposing of high-level radioactive waste from nuclear reactors in extremely deep boreholes. Deep borehole disposal seeks to place the waste as much as 5 kilometres (3.1 mi) beneath the surface of the Earth and relies primarily on the immense natural geological barrier to confine the waste safely and permanently so that it should never pose a threat to the environment. The Earth's crust contains 120 trillion tons of thorium and 40 trillion tons of uranium (primarily at relatively trace concentrations of parts per million each adding up over the crust's 3 × 1019 ton mass), among other natural radioisotopes.

== Clinical implications == The MEN1 phenotype is inherited via an autosomal-dominant pattern and is associated with neoplasms of the pituitary gland, the parathyroid gland, and the pancreas (the 3 "P"s). While these neoplasias are often benign (in contrast to tumours occurring in MEN2A), they are adenomas and, therefore, produce endocrine phenotypes. Pancreatic presentations of the MEN1 phenotype may manifest as Zollinger–Ellison syndrome. MEN1 pituitary tumours are adenomas of anterior cells, typically prolactinomas or growth hormone-secreting. Pancreatic tumours involve the islet cells, giving rise to gastrinomas or insulinomas. In rare cases, adrenal cortex tumours are also seen.

Burger King has been involved in several legal disputes and cases, as both plaintiff and defendant, in the years since its founding in 1954. Depending on the ownership and executive staff at the time of these incidents, the company's responses to these challenges have ranged from a conciliatory dialog with its critics and litigants, to a more aggressive opposition with questionable tactics and negative consequences. The company's response to these various issues has drawn praise as well as, in some instances, suggestions of political appeasement. Legal decisions from suits involving Burger King have set contractual law precedents in regards to long-arm statutes, the limitations of franchise agreements, and ethical business practices. Many of these decisions have helped define general business dealings that continue to shape the entire marketplace.

Sources: en.wikipedia.org

Further detail

Cullen (1860), chief judge of the New York Court of Appeals Egerton Leigh Winthrop (1860), lawyer and socialite Emile Henry Lacombe (1863), judge on the United States Court of Appeals for the Second Circuit Henry Rutgers Beekman (1865), judge on the New York Supreme Court, former corporation counsel of New York City and parks commissioner George Goelet Kip (1865), lawyer, heir and member of the Goelet family George Gosman DeWitt (1867), lawyer, philanthropist, former president of the Saint Nicholas Society of the City of New York Nicholas Fish II (1867), attorney, diplomat, investment banker; son of United States Secretary of State Hamilton Fish Willard Bartlett (1869), chief judge of the New York Court of Appeals Lewis Cass Ledyard* (1871), personal counsel to J. P. Morgan and namesake partner of Carter Ledyard & Milburn, transferred to Harvard University after freshman year Frederic Bronson (1871), lawyer and treasurer for New York Life and Trust Company, grandson of American Revolutionary War surgeon Isaac Bronson Thomas C. Bach (1875), judge on the Supreme Court of the Territory of Montana Francis S. Bangs (1878), attorney at Bangs, Stetson, Tracy, and McVeigh and trustee of Columbia College Frederick William Holls (1878), lawyer, publicist, secretary of the United States delegation to the Hague Peace Conference Edward De Peyster Livingston (1882), lawyer and society leader during the Gilded Age Randolph B. Martine (1885), New York County district attorney 1885–1887 John Vernou Bouvier Jr.

The Purple Book, formally titled Compendium of Macromolecular Terminology and Nomenclature, contains the nomenclature of polymers. The first edition was first published in 1991. The second and latest edition was published in December 2008 and is also available for download.

=== Economics === The sustained-release formulation, Contrave, is marketed by Takeda under license from the combination medication's developer, Orexigen Therapeutics. As of 2015, Orexigen received 20% of net sales from Takeda.

This scaffold and cells were placed in a bioreactor, where it matured to become a partially or fully transplantable organ. the work was called a "landmark". The lab first stripped the cells away from a rat heart (a process called "decellularization") and then injected rat stem cells into the decellularized rat heart. Tissue-engineered blood vessels: Blood vessels that have been grown in a lab and can be used to repair damaged blood vessels without eliciting an immune response. Tissue engineered blood vessels have been developed by many different approaches. They could be implanted as pre-seeded cellularized blood vessels, as acellular vascular grafts made with decellularized vessels or synthetic vascular grafts. Artificial skin constructed from human skin cells embedded in a hydrogel, such as in the case of bio-printed constructs for battlefield burn repairs. Artificial bone marrow: Bone marrow cultured in vitro to be transplanted serves as a "just cells" approach to tissue engineering. Tissue engineered bone: A structural matrix can be composed of metals such as titanium, polymers of varying degradation rates, or certain types of ceramics. Materials are often chosen to recruit osteoblasts to aid in reforming the bone and returning biological function. Various types of cells can be added directly into the matrix to expedite the process. Laboratory-grown penis: Decellularized scaffolds of rabbit penises were recellularised with smooth muscle and endothelial cells.

Sources: en.wikipedia.org

Supporting material

== Early life and education == Chutia was one of the first girls to take Mathematics as a main subject in her school. She later studied physics at Cotton University, Assam where she obtained a BSc in 1967. She continued teaching at Cotton College before obtaining an MSc in physics at Dibrugarh University in 1969. Following this, Chutia taught for some time as a lecturer, eventually deciding to continue with research by pursuing a PhD at Dibrugarh University on a fellowship in 1976. Her research focused on the conduction mechanism of thin polymer films and she was awarded her degree in 1981.

Acheson SA, Kirkman HN, Wolfenden R (1988). "Equilibrium of 5,6-hydration of NADH and mechanism of ATP-dependent dehydration". Biochemistry. 27 (19): 7371–5. doi:10.1021/bi00419a030. PMID 3061454. MEINHART JO, CHAYKIN S, KREBS EG (1956). "Enzymatic conversion of a reduced diphosphopyridine nucleotide derivative to reduced diphosphopyridine nucleotide". J. Biol. Chem. 220 (2): 821–9. doi:10.1016/S0021-9258(18)65307-4. PMID 13331940. Regueiro V, Campos MA, Pons J, Alberti S, Bengoechea JA (2006). "The uptake of a Klebsiella pneumoniae capsule polysaccharide mutant triggers an inflammatory response by human airway epithelial cells". Microbiology. 152 (Pt 2): 555–66. doi:10.1099/mic.0.28285-0. PMID 16436443.

When transmembrane proteins are translated from RNA they have start-transfer-sequences and stop-transfer-sequences before their posttranslational modifications occurs. The start-transfer-sequence is used to recruit a signal recognition particle(SRP) which consequently stops translation until it binds to a SRP-receptor on the surface of the lipid bilayer. Translocons are channels in the membrane which allow proteins to be moved across the membrane and the Ribosome synthesizes the polypeptide directly through it. The start-transfer-sequence is attached to the Translocon and is cleaved posttranslationally along with the stop-transfer-sequence. Many other complex pathways for embedding proteins exist, specific to eukaryotes and prokaryotes respectively.

Sources: en.wikipedia.org

Frequently asked questions

What is thymosin alpha 1?

It is a 28-amino-acid peptide originally purified from a bovine thymic extract and later produced synthetically. It is studied mainly for its effects on immune cell function.

Is thymosin alpha 1 the same as thymosin beta 4?

No. The two peptides share part of a name but differ in length, sequence, and net charge. Literature searches that treat them as one compound return misleading results.

How is the peptide obtained for laboratory work?

Solid-phase peptide synthesis is the usual route, and recombinant expression has also been described. Both approaches produce material matching the natural sequence.

Is thymosin alpha-1 a hormone?

It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.

Network